SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-018410
Filing Date
2021-03-05
Accepted
2021-03-05 20:00:19
Documents
1
Period of Report
2021-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8677
  Complete submission text file 0001209191-21-018410.txt   10331
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET STE 415 CAMBRIDGE MA 02142
Business Address
Brown Ryan Edward (Reporting) CIK: 0001848718 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14895 | Film No.: 21720328